GGrantIndex
← Leaderboards

Michael J Prerau

Massachusetts General Hospital

$6,587,030
Attributed
$14,356,113
Total exposure
5
Grants
2
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $4.7M · FY201625
$5M$3.8M$2.5M$1.3M$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$14,356,113 · 5

By mechanism

R01$11,312,867 · 3
RF1$2,576,936 · 1
R21$466,310 · 1

Top collaborators

Most similar at Massachusetts General Hospital

Same institution · by research overlap

Others in their field

Top investigators on “Alzheimer&Apos

Research focus

Alzheimer&AposBrainSleepS DiseaseSignal ProcessingBiological MarkersBrain RegionNeurophysiologyBaseElectroencephalogramNon Rapid Eye MovementPathologicDiagnosisVariantLinkSleep DisturbancesMental DisordersCerebrumAmyloid Beta-ProteinCognitiveAmyloidFrequenciesMagnetic Resonance ImagingBasal Forebrain

Grant awards (17)

Characterizing sleep brain dynamics associated with Alzheimer's disease pathology and progression in humans using EEG source localization and PET$1,637,641
R01 · FY2025 · AG
Characterizing sleep brain dynamics associated with Alzheimer's disease pathology and progression in humans using EEG source localization and PET$1,686,029
R01 · FY2024 · AG
Sleep Spindle Dynamics as a Clinical Biomarker of Aging, Alzheimer's Disease, and Trisomy 21$2,576,936
RF1 · FY2023 · AG · contact PI
Characterizing sleep brain dynamics associated with Alzheimer's disease pathology and progression in humans using EEG source localization and PET$1,871,738
R01 · FY2023 · AG
Role of lateral hypothalamus projections in opioid withdrawal-induced sleep deficits$209,794
R21 · FY2023 · DA
Role of lateral hypothalamus projections in opioid withdrawal-induced sleep deficits$256,516
R21 · FY2022 · DA
Noninvasive Low-cost Biomarkers for Preclinical Diagnosis and Longitudinal Tracking of Alzheimer's Disease Using Sleep and Resting State EEG$811,850
R01 · FY2021 · AG
Noninvasive Low-cost Biomarkers for Preclinical Diagnosis and Longitudinal Tracking of Alzheimer's Disease Using Sleep and Resting State EEG$826,867
R01 · FY2020 · AG
Modeling Multi-scale Sleep EEG Dynamics as a Framework for Biomarker Discovery$400,732
R01 · FY2020 · NS · contact PI
Noninvasive Low-cost Biomarkers for Preclinical Diagnosis and Longitudinal Tracking of Alzheimer's Disease Using Sleep and Resting State EEG$837,363
R01 · FY2019 · AG
Modeling Multi-scale Sleep EEG Dynamics as a Framework for Biomarker Discovery$288,946
R01 · FY2019 · NS · contact PI
Modeling Multi-scale Sleep EEG Dynamics as a Framework for Biomarker Discovery$92,758
R01 · FY2019 · NS · contact PI
Noninvasive Low-cost Biomarkers for Preclinical Diagnosis and Longitudinal Tracking of Alzheimer's Disease Using Sleep and Resting State EEG$844,721
R01 · FY2018 · AG
Modeling Multi-scale Sleep EEG Dynamics as a Framework for Biomarker Discovery$381,262
R01 · FY2018 · NS · contact PI
Noninvasive Low-cost Biomarkers for Preclinical Diagnosis and Longitudinal Tracking of Alzheimer's Disease Using Sleep and Resting State EEG$854,981
R01 · FY2017 · AG
Modeling Multi-scale Sleep EEG Dynamics as a Framework for Biomarker Discovery$382,636
R01 · FY2017 · NS · contact PI
Modeling Multi-scale Sleep EEG Dynamics as a Framework for Biomarker Discovery$395,343
R01 · FY2016 · NS · contact PI